Neoleukin Therapeutics (NLTX) Q4 2022 Earnings

Mar 20Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.3
-0.27
-0.24
-0.21

Details

Expected EPS
-0.21
Actual EPS
-0.24
Surprise EPS
-0.03
Surprise Percent
-14.29%

Description

⁨Neoleukin Therapeutics⁩ (⁦NLTX⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts